TIGAN Drug Patent Profile
✉ Email this page to a colleague
When do Tigan patents expire, and what generic alternatives are available?
Tigan is a drug marketed by King Pharms Llc and Endo Operations and is included in two NDAs.
The generic ingredient in TIGAN is trimethobenzamide hydrochloride. There are six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the trimethobenzamide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tigan
A generic version of TIGAN was approved as trimethobenzamide hydrochloride by LUPIN on August 20th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TIGAN?
- What are the global sales for TIGAN?
- What is Average Wholesale Price for TIGAN?
Summary for TIGAN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 68 |
| Patent Applications: | 405 |
| Drug Prices: | Drug price information for TIGAN |
| What excipients (inactive ingredients) are in TIGAN? | TIGAN excipients list |
| DailyMed Link: | TIGAN at DailyMed |
Pharmacology for TIGAN
| Drug Class | Antiemetic |
| Physiological Effect | Emesis Suppression |
US Patents and Regulatory Information for TIGAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| King Pharms Llc | TIGAN | trimethobenzamide hydrochloride | CAPSULE;ORAL | 017531-006 | Dec 13, 2001 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Endo Operations | TIGAN | trimethobenzamide hydrochloride | INJECTABLE;INJECTION | 017530-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
